DLBCL ISPOR 2019 New Orleans

PubMed search terms for "Lifetime Costs for Diffuse Large B-Cell Lymphoma and B-Cell Acute Lymphoblastic Leukemia: A Literature Review to Inform Potential Financial Impact of Curative Therapies" by Jonathan Salcedo, MA and Colin M. Young, PhD.

DLBCL:
("lymphoma, large b-cell, diffuse"[MeSH Terms] OR ("lymphoma"[All Fields] AND "large"[All Fields] AND "b-cell"[All Fields] AND "diffuse"[All Fields]) OR "diffuse large b-cell lymphoma"[All Fields] OR "dlbcl"[All Fields]) AND ("economics"[Subheading] OR "economics"[All Fields] OR "cost"[All Fields] OR "costs and cost analysis"[MeSH Terms] OR ("costs"[All Fields] AND "cost"[All Fields] AND "analysis"[All Fields]) OR "costs and cost analysis"[All Fields])

B-ALL:
("acute lymphoblastic leukaemia"[All Fields] OR "precursor cell lymphoblastic leukemia-lymphoma"[MeSH Terms] OR ("precursor"[All Fields] AND "cell"[All Fields] AND "lymphoblastic"[All Fields] AND "leukemia-lymphoma"[All Fields]) OR "precursor cell lymphoblastic leukemia-lymphoma"[All Fields] OR ("acute"[All Fields] AND "lymphoblastic"[All Fields] AND "leukemia"[All Fields]) OR "acute lymphoblastic leukemia"[All Fields]) AND ("b-lymphocytes"[MeSH Terms] OR "b-lymphocytes"[All Fields] OR "b cell"[All Fields]) AND ("economics"[Subheading] OR "economics"[All Fields] OR "cost"[All Fields] OR "costs and cost analysis"[MeSH Terms] OR ("costs"[All Fields] AND "cost"[All Fields] AND "analysis"[All Fields]) OR "costs and cost analysis"[All Fields])